Global and United States Immuno-oncology Drugs Market Insights, Forecast to 2026

Global and United States Immuno-oncology Drugs Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Immuno-oncology Drugs Product Introduction
1.2 Market Segments
1.3 Key Immuno-oncology Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Immuno-oncology Drugs Market Size Growth Rate by Type
1.4.2 Immune Checkpoint Inhibitors
1.4.3 Monoclonal Antibodies
1.4.4 Cytokine-Based Immunotherapy
1.4.5 Cancer Vaccines
1.4.6 CAR-T Cell Therapy
1.5 Market by Application
1.5.1 Global Immuno-oncology Drugs Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Immuno-oncology Drugs Market Size, Estimates and Forecasts
2.1.1 Global Immuno-oncology Drugs Revenue 2015-2026
2.1.2 Global Immuno-oncology Drugs Sales 2015-2026
2.2 Global Immuno-oncology Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Immuno-oncology Drugs Historical Market Size by Region (2015-2020)
2.3.1 Global Immuno-oncology Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Immuno-oncology Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Immuno-oncology Drugs Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Immuno-oncology Drugs Sales Forecast by Region (2021-2026)
2.4.2 Global Immuno-oncology Drugs Revenue Forecast by Region (2021-2026)
3 Global Immuno-oncology Drugs Competitor Landscape by Players
3.1 Global Top Immuno-oncology Drugs Sales by Manufacturers
3.1.1 Global Immuno-oncology Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Immuno-oncology Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Global Immuno-oncology Drugs Manufacturers by Revenue
3.2.1 Global Immuno-oncology Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Immuno-oncology Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Immuno-oncology Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Immuno-oncology Drugs Revenue in 2019
3.2.5 Global Immuno-oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Immuno-oncology Drugs Price by Manufacturers
3.4 Global Immuno-oncology Drugs Manufacturing Base Distribution, Product Types
3.4.1 Immuno-oncology Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Immuno-oncology Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Immuno-oncology Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Immuno-oncology Drugs Market Size by Type (2015-2020)
4.1.1 Global Immuno-oncology Drugs Sales by Type (2015-2020)
4.1.2 Global Immuno-oncology Drugs Revenue by Type (2015-2020)
4.1.3 Immuno-oncology Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Immuno-oncology Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Immuno-oncology Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Immuno-oncology Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Immuno-oncology Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Immuno-oncology Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Immuno-oncology Drugs Market Size by Application (2015-2020)
5.1.1 Global Immuno-oncology Drugs Sales by Application (2015-2020)
5.1.2 Global Immuno-oncology Drugs Revenue by Application (2015-2020)
5.1.3 Immuno-oncology Drugs Price by Application (2015-2020)
5.2 Immuno-oncology Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Immuno-oncology Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Immuno-oncology Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Immuno-oncology Drugs Price Forecast by Application (2021-2026)
6 United States by Players, Type and Application
6.1 United States Immuno-oncology Drugs Market Size YoY Growth 2015-2026
6.1.1 United States Immuno-oncology Drugs Sales YoY Growth 2015-2026
6.1.2 United States Immuno-oncology Drugs Revenue YoY Growth 2015-2026
6.1.3 United States Immuno-oncology Drugs Market Share in Global Market 2015-2026
6.2 United States Immuno-oncology Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Immuno-oncology Drugs Players by Sales (2015-2020)
6.2.2 United States Top Immuno-oncology Drugs Players by Revenue (2015-2020)
6.3 United States Immuno-oncology Drugs Historic Market Review by Type (2015-2020)
6.3.1 United States Immuno-oncology Drugs Sales Market Share by Type (2015-2020)
6.3.2 United States Immuno-oncology Drugs Revenue Market Share by Type (2015-2020)
6.3.3 United States Immuno-oncology Drugs Price by Type (2015-2020)
6.4 United States Immuno-oncology Drugs Market Estimates and Forecasts by Type (2021-2026)
6.4.1 United States Immuno-oncology Drugs Sales Forecast by Type (2021-2026)
6.4.2 United States Immuno-oncology Drugs Revenue Forecast by Type (2021-2026)
6.4.3 United States Immuno-oncology Drugs Price Forecast by Type (2021-2026)
6.5 United States Immuno-oncology Drugs Historic Market Review by Application (2015-2020)
6.5.1 United States Immuno-oncology Drugs Sales Market Share by Application (2015-2020)
6.5.2 United States Immuno-oncology Drugs Revenue Market Share by Application (2015-2020)
6.5.3 United States Immuno-oncology Drugs Price by Application (2015-2020)
6.6 United States Immuno-oncology Drugs Market Estimates and Forecasts by Application (2021-2026)
6.6.1 United States Immuno-oncology Drugs Sales Forecast by Application (2021-2026)
6.6.2 United States Immuno-oncology Drugs Revenue Forecast by Application (2021-2026)
6.6.3 United States Immuno-oncology Drugs Price Forecast by Application (2021-2026)
7 North America
7.1 North America Immuno-oncology Drugs Market Size YoY Growth 2015-2026
7.2 North America Immuno-oncology Drugs Market Facts & Figures by Country
7.2.1 North America Immuno-oncology Drugs Sales by Country (2015-2020)
7.2.2 North America Immuno-oncology Drugs Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Immuno-oncology Drugs Market Size YoY Growth 2015-2026
8.2 Europe Immuno-oncology Drugs Market Facts & Figures by Country
8.2.1 Europe Immuno-oncology Drugs Sales by Country
8.2.2 Europe Immuno-oncology Drugs Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Immuno-oncology Drugs Market Size YoY Growth 2015-2026
9.2 Asia Pacific Immuno-oncology Drugs Market Facts & Figures by Country
9.2.1 Asia Pacific Immuno-oncology Drugs Sales by Region (2015-2020)
9.2.2 Asia Pacific Immuno-oncology Drugs Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Immuno-oncology Drugs Market Size YoY Growth 2015-2026
10.2 Latin America Immuno-oncology Drugs Market Facts & Figures by Country
10.2.1 Latin America Immuno-oncology Drugs Sales by Country
10.2.2 Latin America Immuno-oncology Drugs Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Immuno-oncology Drugs Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Immuno-oncology Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Immuno-oncology Drugs Sales by Country
11.2.2 Middle East and Africa Immuno-oncology Drugs Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Amgen, Inc
12.1.1 Amgen, Inc Corporation Information
12.1.2 Amgen, Inc Description and Business Overview
12.1.3 Amgen, Inc Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Amgen, Inc Immuno-oncology Drugs Products Offered
12.1.5 Amgen, Inc Recent Development
12.2 AstraZeneca, Plc
12.2.1 AstraZeneca, Plc Corporation Information
12.2.2 AstraZeneca, Plc Description and Business Overview
12.2.3 AstraZeneca, Plc Sales, Revenue and Gross Margin (2015-2020)
12.2.4 AstraZeneca, Plc Immuno-oncology Drugs Products Offered
12.2.5 AstraZeneca, Plc Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Corporation Information
12.3.2 Bristol-Myers Squibb Description and Business Overview
12.3.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bristol-Myers Squibb Immuno-oncology Drugs Products Offered
12.3.5 Bristol-Myers Squibb Recent Development
12.4 Celgene Corporation
12.4.1 Celgene Corporation Corporation Information
12.4.2 Celgene Corporation Description and Business Overview
12.4.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Celgene Corporation Immuno-oncology Drugs Products Offered
12.4.5 Celgene Corporation Recent Development
12.5 Eli Lilly and Company
12.5.1 Eli Lilly and Company Corporation Information
12.5.2 Eli Lilly and Company Description and Business Overview
12.5.3 Eli Lilly and Company Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Eli Lilly and Company Immuno-oncology Drugs Products Offered
12.5.5 Eli Lilly and Company Recent Development
12.6 Merck & Co.
12.6.1 Merck & Co. Corporation Information
12.6.2 Merck & Co. Description and Business Overview
12.6.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Merck & Co. Immuno-oncology Drugs Products Offered
12.6.5 Merck & Co. Recent Development
12.7 Hoffmann-La Roche AG
12.7.1 Hoffmann-La Roche AG Corporation Information
12.7.2 Hoffmann-La Roche AG Description and Business Overview
12.7.3 Hoffmann-La Roche AG Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hoffmann-La Roche AG Immuno-oncology Drugs Products Offered
12.7.5 Hoffmann-La Roche AG Recent Development
12.8 Johnson & Johnson
12.8.1 Johnson & Johnson Corporation Information
12.8.2 Johnson & Johnson Description and Business Overview
12.8.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Johnson & Johnson Immuno-oncology Drugs Products Offered
12.8.5 Johnson & Johnson Recent Development
12.9 Novartis International AG
12.9.1 Novartis International AG Corporation Information
12.9.2 Novartis International AG Description and Business Overview
12.9.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Novartis International AG Immuno-oncology Drugs Products Offered
12.9.5 Novartis International AG Recent Development
12.10 AbbVie, Inc.
12.10.1 AbbVie, Inc. Corporation Information
12.10.2 AbbVie, Inc. Description and Business Overview
12.10.3 AbbVie, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 AbbVie, Inc. Immuno-oncology Drugs Products Offered
12.10.5 AbbVie, Inc. Recent Development
12.11 Amgen, Inc
12.11.1 Amgen, Inc Corporation Information
12.11.2 Amgen, Inc Description and Business Overview
12.11.3 Amgen, Inc Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Amgen, Inc Immuno-oncology Drugs Products Offered
12.11.5 Amgen, Inc Recent Development
12.12 Sanofi S.A.
12.12.1 Sanofi S.A. Corporation Information
12.12.2 Sanofi S.A. Description and Business Overview
12.12.3 Sanofi S.A. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Sanofi S.A. Products Offered
12.12.5 Sanofi S.A. Recent Development
12.13 EMD Serono, Inc.
12.13.1 EMD Serono, Inc. Corporation Information
12.13.2 EMD Serono, Inc. Description and Business Overview
12.13.3 EMD Serono, Inc. Sales, Revenue and Gross Margin (2015-2020)
12.13.4 EMD Serono, Inc. Products Offered
12.13.5 EMD Serono, Inc. Recent Development
12.14 Gilead Sciences Inc.
12.14.1 Gilead Sciences Inc. Corporation Information
12.14.2 Gilead Sciences Inc. Description and Business Overview
12.14.3 Gilead Sciences Inc. Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Gilead Sciences Inc. Products Offered
12.14.5 Gilead Sciences Inc. Recent Development
12.15 Prometheus Therapeutics & Diagnostics
12.15.1 Prometheus Therapeutics & Diagnostics Corporation Information
12.15.2 Prometheus Therapeutics & Diagnostics Description and Business Overview
12.15.3 Prometheus Therapeutics & Diagnostics Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Prometheus Therapeutics & Diagnostics Products Offered
12.15.5 Prometheus Therapeutics & Diagnostics Recent Development
12.16 Aduro BioTech
12.16.1 Aduro BioTech Corporation Information
12.16.2 Aduro BioTech Description and Business Overview
12.16.3 Aduro BioTech Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Aduro BioTech Products Offered
12.16.5 Aduro BioTech Recent Development
12.17 Galena Biopharma
12.17.1 Galena Biopharma Corporation Information
12.17.2 Galena Biopharma Description and Business Overview
12.17.3 Galena Biopharma Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Galena Biopharma Products Offered
12.17.5 Galena Biopharma Recent Development
12.18 Bavarian Nordic
12.18.1 Bavarian Nordic Corporation Information
12.18.2 Bavarian Nordic Description and Business Overview
12.18.3 Bavarian Nordic Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Bavarian Nordic Products Offered
12.18.5 Bavarian Nordic Recent Development
12.19 Celldex Therapeutics
12.19.1 Celldex Therapeutics Corporation Information
12.19.2 Celldex Therapeutics Description and Business Overview
12.19.3 Celldex Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Celldex Therapeutics Products Offered
12.19.5 Celldex Therapeutics Recent Development
12.20 ImmunoCellular Therapeutics
12.20.1 ImmunoCellular Therapeutics Corporation Information
12.20.2 ImmunoCellular Therapeutics Description and Business Overview
12.20.3 ImmunoCellular Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.20.4 ImmunoCellular Therapeutics Products Offered
12.20.5 ImmunoCellular Therapeutics Recent Development
12.21 Incyte
12.21.1 Incyte Corporation Information
12.21.2 Incyte Description and Business Overview
12.21.3 Incyte Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Incyte Products Offered
12.21.5 Incyte Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Immuno-oncology Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Immuno-oncology Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Immuno-oncology Drugs Market Segments
Table 2. Ranking of Global Top Immuno-oncology Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Immuno-oncology Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Immune Checkpoint Inhibitors
Table 5. Major Manufacturers of Monoclonal Antibodies
Table 6. Major Manufacturers of Cytokine-Based Immunotherapy
Table 7. Major Manufacturers of Cancer Vaccines
Table 8. Major Manufacturers of CAR-T Cell Therapy
Table 9. Global Immuno-oncology Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 10. Global Immuno-oncology Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 11. Global Immuno-oncology Drugs Sales by Regions 2015-2020 (K Units)
Table 12. Global Immuno-oncology Drugs Sales Market Share by Regions (2015-2020)
Table 13. Global Immuno-oncology Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Immuno-oncology Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 15. Global Immuno-oncology Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 16. Global Immuno-oncology Drugs Sales Share by Manufacturers (2015-2020)
Table 17. Global Immuno-oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Immuno-oncology Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immuno-oncology Drugs as of 2019)
Table 19. Immuno-oncology Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Immuno-oncology Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Immuno-oncology Drugs Price (2015-2020) (USD/Unit)
Table 22. Immuno-oncology Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Immuno-oncology Drugs Product Type
Table 24. Date of International Manufacturers Enter into Immuno-oncology Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Immuno-oncology Drugs Sales by Type (2015-2020) (K Units)
Table 27. Global Immuno-oncology Drugs Sales Share by Type (2015-2020)
Table 28. Global Immuno-oncology Drugs Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Immuno-oncology Drugs Revenue Share by Type (2015-2020)
Table 30. Immuno-oncology Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 31. Global Immuno-oncology Drugs Sales Share by Type (2021-2026)
Table 32. Global Immuno-oncology Drugs Sales by Application (2015-2020) (K Units)
Table 33. Global Immuno-oncology Drugs Sales Share by Application (2015-2020)
Table 34. Global Immuno-oncology Drugs Sales Share by Application (2021-2026)
Table 35. Global Immuno-oncology Drugs Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Immuno-oncology Drugs Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Immuno-oncology Drugs Revenue Market Share Forecast by Application (2021-2026)
Table 38. United States Immuno-oncology Drugs Sales (K Units) of Key Companies (2015-2020)
Table 39. United States Immuno-oncology Drugs Sales Share by Company (2015-2020)
Table 40. United States Immuno-oncology Drugs Revenue (US$ Million) by Company (2015-2020)
Table 41. United States Immuno-oncology Drugs Sales (K Units) by Type (2015-2020)
Table 42. United States Immuno-oncology Drugs Sales Share by Type (2015-2020)
Table 43. United States Immuno-oncology Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. United States Immuno-oncology Drugs Price (K Units) by Type (2015-2020)
Table 45. United States Immuno-oncology Drugs Sales (K Units) by Type (2021-2026)
Table 46. United States Immuno-oncology Drugs Sales Share by Type (2021-2026)
Table 47. United States Immuno-oncology Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. United States Immuno-oncology Drugs Revenue Share by Type (2021-2026)
Table 49. United States Immuno-oncology Drugs Price (K Units) by Type (2021-2026)
Table 50. United States Immuno-oncology Drugs Sales (K Units) by Application (2015-2020)
Table 51. United States Immuno-oncology Drugs Sales Share by Application (2015-2020)
Table 52. United States Immuno-oncology Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. United States Immuno-oncology Drugs Sales (K Units) by Application (2021-2026)
Table 54. United States Immuno-oncology Drugs Sales Share by Application (2021-2026)
Table 55. United States Immuno-oncology Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. United States Immuno-oncology Drugs Revenue Share by Application (2021-2026)
Table 57. North America Immuno-oncology Drugs Sales by Country (2015-2020) (K Units)
Table 58. North America Immuno-oncology Drugs Sales Market Share by Country (2015-2020)
Table 59. North America Immuno-oncology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Immuno-oncology Drugs Revenue Market Share by Country (2015-2020)
Table 61. Europe Immuno-oncology Drugs Sales by Country (2015-2020) (K Units)
Table 62. Europe Immuno-oncology Drugs Sales Market Share by Country (2015-2020)
Table 63. Europe Immuno-oncology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Immuno-oncology Drugs Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Immuno-oncology Drugs Sales by Region (2015-2020) (K Units)
Table 66. Asia Pacific Immuno-oncology Drugs Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Immuno-oncology Drugs Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Immuno-oncology Drugs Revenue Market Share by Region (2015-2020)
Table 69. Latin America Immuno-oncology Drugs Sales by Country (2015-2020) (K Units)
Table 70. Latin America Immuno-oncology Drugs Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Immuno-oncology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Immuno-oncology Drugs Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Immuno-oncology Drugs Sales by Country (2015-2020) (K Units)
Table 74. Middle East and Africa Immuno-oncology Drugs Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Immuno-oncology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Immuno-oncology Drugs Revenue Market Share by Country (2015-2020)
Table 77. Amgen, Inc Corporation Information
Table 78. Amgen, Inc Description and Business Overview
Table 79. Amgen, Inc Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Amgen, Inc Immuno-oncology Drugs Product
Table 81. Amgen, Inc Recent Development
Table 82. AstraZeneca, Plc Corporation Information
Table 83. AstraZeneca, Plc Description and Business Overview
Table 84. AstraZeneca, Plc Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. AstraZeneca, Plc Product
Table 86. AstraZeneca, Plc Recent Development
Table 87. Bristol-Myers Squibb Corporation Information
Table 88. Bristol-Myers Squibb Description and Business Overview
Table 89. Bristol-Myers Squibb Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Bristol-Myers Squibb Product
Table 91. Bristol-Myers Squibb Recent Development
Table 92. Celgene Corporation Corporation Information
Table 93. Celgene Corporation Description and Business Overview
Table 94. Celgene Corporation Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Celgene Corporation Product
Table 96. Celgene Corporation Recent Development
Table 97. Eli Lilly and Company Corporation Information
Table 98. Eli Lilly and Company Description and Business Overview
Table 99. Eli Lilly and Company Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Eli Lilly and Company Product
Table 101. Eli Lilly and Company Recent Development
Table 102. Merck & Co. Corporation Information
Table 103. Merck & Co. Description and Business Overview
Table 104. Merck & Co. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Merck & Co. Product
Table 106. Merck & Co. Recent Development
Table 107. Hoffmann-La Roche AG Corporation Information
Table 108. Hoffmann-La Roche AG Description and Business Overview
Table 109. Hoffmann-La Roche AG Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Hoffmann-La Roche AG Product
Table 111. Hoffmann-La Roche AG Recent Development
Table 112. Johnson & Johnson Corporation Information
Table 113. Johnson & Johnson Description and Business Overview
Table 114. Johnson & Johnson Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Johnson & Johnson Product
Table 116. Johnson & Johnson Recent Development
Table 117. Novartis International AG Corporation Information
Table 118. Novartis International AG Description and Business Overview
Table 119. Novartis International AG Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Novartis International AG Product
Table 121. Novartis International AG Recent Development
Table 122. AbbVie, Inc. Corporation Information
Table 123. AbbVie, Inc. Description and Business Overview
Table 124. AbbVie, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 125. AbbVie, Inc. Product
Table 126. AbbVie, Inc. Recent Development
Table 127. Pfizer Inc. Corporation Information
Table 128. Pfizer Inc. Description and Business Overview
Table 129. Pfizer Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. Pfizer Inc. Product
Table 131. Pfizer Inc. Recent Development
Table 132. Sanofi S.A. Corporation Information
Table 133. Sanofi S.A. Description and Business Overview
Table 134. Sanofi S.A. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 135. Sanofi S.A. Product
Table 136. Sanofi S.A. Recent Development
Table 137. EMD Serono, Inc. Corporation Information
Table 138. EMD Serono, Inc. Description and Business Overview
Table 139. EMD Serono, Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 140. EMD Serono, Inc. Product
Table 141. EMD Serono, Inc. Recent Development
Table 142. Gilead Sciences Inc. Corporation Information
Table 143. Gilead Sciences Inc. Description and Business Overview
Table 144. Gilead Sciences Inc. Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 145. Gilead Sciences Inc. Product
Table 146. Gilead Sciences Inc. Recent Development
Table 147. Prometheus Therapeutics & Diagnostics Corporation Information
Table 148. Prometheus Therapeutics & Diagnostics Description and Business Overview
Table 149. Prometheus Therapeutics & Diagnostics Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 150. Prometheus Therapeutics & Diagnostics Product
Table 151. Prometheus Therapeutics & Diagnostics Recent Development
Table 152. Aduro BioTech Corporation Information
Table 153. Aduro BioTech Description and Business Overview
Table 154. Aduro BioTech Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 155. Aduro BioTech Product
Table 156. Aduro BioTech Recent Development
Table 157. Galena Biopharma Corporation Information
Table 158. Galena Biopharma Description and Business Overview
Table 159. Galena Biopharma Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 160. Galena Biopharma Product
Table 161. Galena Biopharma Recent Development
Table 162. Bavarian Nordic Corporation Information
Table 163. Bavarian Nordic Description and Business Overview
Table 164. Bavarian Nordic Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 165. Bavarian Nordic Product
Table 166. Bavarian Nordic Recent Development
Table 167. Celldex Therapeutics Corporation Information
Table 168. Celldex Therapeutics Description and Business Overview
Table 169. Celldex Therapeutics Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 170. Celldex Therapeutics Product
Table 171. Celldex Therapeutics Recent Development
Table 172. ImmunoCellular Therapeutics Corporation Information
Table 173. ImmunoCellular Therapeutics Description and Business Overview
Table 174. ImmunoCellular Therapeutics Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 175. ImmunoCellular Therapeutics Product
Table 176. ImmunoCellular Therapeutics Recent Development
Table 177. Incyte Corporation Information
Table 178. Incyte Description and Business Overview
Table 179. Incyte Immuno-oncology Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 180. Incyte Product
Table 181. Incyte Recent Development
Table 182. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 183. Key Challenges
Table 184. Market Risks
Table 185. Main Points Interviewed from Key Immuno-oncology Drugs Players
Table 186. Immuno-oncology Drugs Customers List
Table 187. Immuno-oncology Drugs Distributors List
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Immuno-oncology Drugs Product Picture
Figure 2. Global Immuno-oncology Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Immune Checkpoint Inhibitors Product Picture
Figure 4. Monoclonal Antibodies Product Picture
Figure 5. Cytokine-Based Immunotherapy Product Picture
Figure 6. Cancer Vaccines Product Picture
Figure 7. CAR-T Cell Therapy Product Picture
Figure 8. Global Immuno-oncology Drugs Sales Market Share by Application in 2020 & 2026
Figure 9. Hospitals
Figure 10. Pharmacies
Figure 11. Online Pharmacies
Figure 12. Immuno-oncology Drugs Report Years Considered
Figure 13. Global Immuno-oncology Drugs Market Size 2015-2026 (US$ Million)
Figure 14. Global Immuno-oncology Drugs Sales 2015-2026 (K Units)
Figure 15. Global Immuno-oncology Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Immuno-oncology Drugs Sales Market Share by Region (2015-2020)
Figure 17. Global Immuno-oncology Drugs Sales Market Share by Region in 2019
Figure 18. Global Immuno-oncology Drugs Revenue Market Share by Region (2015-2020)
Figure 19. Global Immuno-oncology Drugs Revenue Market Share by Region in 2019
Figure 20. Global Immuno-oncology Drugs Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Immuno-oncology Drugs Revenue in 2019
Figure 22. Immuno-oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Immuno-oncology Drugs Sales Market Share by Type (2015-2020)
Figure 24. Global Immuno-oncology Drugs Sales Market Share by Type in 2019
Figure 25. Global Immuno-oncology Drugs Revenue Market Share by Type (2015-2020)
Figure 26. Global Immuno-oncology Drugs Revenue Market Share by Type in 2019
Figure 27. Global Immuno-oncology Drugs Market Share by Price Range (2015-2020)
Figure 28. Global Immuno-oncology Drugs Sales Market Share by Application (2015-2020)
Figure 29. Global Immuno-oncology Drugs Sales Market Share by Application in 2019
Figure 30. Global Immuno-oncology Drugs Revenue Market Share by Application (2015-2020)
Figure 31. Global Immuno-oncology Drugs Revenue Market Share by Application in 2019
Figure 32. United States Immuno-oncology Drugs Sales Growth Rate 2015-2026 (K Units)
Figure 33. United States Immuno-oncology Drugs Revenue Growth Rate 2015-2026 (US$ Million)
Figure 34. United States Immuno-oncology Drugs Market Share in Global Market 2015-2026
Figure 35. United States 5 and 10 Largest Immuno-oncology Drugs Players Market Share by Revenue in Immuno-oncology Drugs in 2019
Figure 36. United States Immuno-oncology Drugs Revenue Share by Type (2015-2020)
Figure 37. United States Immuno-oncology Drugs Revenue Growt

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs